App review

MacroFactor for GLP-1 patients — review

MacroFactor's adaptive-target algorithm handles the moving target of decreasing maintenance calories during GLP-1 weight loss well. No dedicated GLP-1 mode and no permanent free tier are the main limitations.

MacroFactor is built around an adaptive-target algorithm that continually re-estimates the user’s maintenance calories from their logged intake and weight trend. For GLP-1 receptor agonist patients — whose effective intake and energy expenditure both change as the dose escalates — the adaptive design is a substantive advantage over fixed-target trackers.

Why an adaptive target matters on GLP-1

Most calorie-tracking apps ask the user to choose a fixed daily calorie target at setup and assume that target stays valid. On GLP-1 therapy, two things change over the first 6-12 months:

1. Effective intake declines as the medication is titrated upward — the patient may settle into intake patterns 30-50% below their pre-medication baseline without consciously trying to.
2. Body weight declines, which mechanically lowers the maintenance-calorie level (a smaller body costs fewer calories to maintain).

A fixed-target tracker becomes increasingly stale across this interval. A patient whose original target was 1,800 kcal/day at month one may be at a maintenance level of 1,400-1,500 kcal/day by month nine. Without the adaptive recalculation, the tracker is suggesting a deficit the patient does not need (and that pushes them toward inadequate protein and micronutrient intake).

MacroFactor’s algorithm handles this well. The continuous recalibration is the app’s primary distinguishing feature.

What MacroFactor does not do

• No dedicated GLP-1 mode. MacroFactor’s product framing remains the recreational-fitness and physique-tracking audience; GLP-1 patients have to fit themselves into that framing.
• No permanent free tier. Unlike PlateLens, MyNetDiary, Cronometer, and Lose It!, MacroFactor offers only a free trial period followed by paid subscription. For patients who want to test-drive a tracker for several months before committing, this is a real limitation.
• Photo logging is limited. Typed entry and barcode are the primary workflow.
• Coaching content is generally good but assumes a degree of macronutrient literacy that not all GLP-1 patients have at the start.

Editorial assessment

MacroFactor is a defensible pick for GLP-1 patients who are already comfortable with macronutrient tracking and want the adaptive-maintenance feature. The clearest case for MacroFactor over PlateLens is the adaptive-target algorithm; the clearest case against is the lack of a free tier, the limited photo logging, and the fitness-audience framing.

For most GLP-1 patients in the editorial team’s clinical experience, PlateLens or MyNetDiary GLP-1 will fit better at the start of therapy; MacroFactor becomes more interesting in months 6-18 when the patient is comfortable with macronutrient logging and wants the adaptive feature.

References

1. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021;384(11):989-1002.
2. Heymsfield SB, Aronne LJ, Eneli I, et al. Energy expenditure and energy gap during pharmacologic weight loss: implications for nutritional targeting. Obesity. 2024;32(9):1655-1664.
3. Holmstrup ME, Fairman CM, Calanna S, et al. Body composition during pharmacologic weight loss with GLP-1 receptor agonists: implications for protein adequacy and resistance training. Obesity Reviews. 2025;26(4):e13721.

GLP-1 Nutrition does not accept payment, affiliate revenue, or sponsorship from any app developer. App reviews are funded by editorial budget only. Editorial policy: /about/editorial-policy/.